5-amino-1mq human study (10 mg) Research Peptide – Genuine Peptides 5-amino-1MQ 50 mg – lyophilized

PMID 16990188

GLP-1 brings together two active ingredients that work on complementary pathways: Semaglutide is a GLP-1 receptor agonist

, University of Miami Metabolic & nutritional medicine Dr

Standard AOD-9604 Dosing Protocol Typical Dosing Range: Standard Dose: 250-500 mcg per day Clinical Trial Dose: 1 mg (1,000 mcg) per day (most effective in studies) Conservative Start: 250 mcg per day for first week Maintenance Range: 500 mcg per day for sustained protocols Frequency: Once daily, typically before breakfast Timing Rationale: Morning fasted state maximizes fat oxidation potential Cycle Length: 12-24 weeks for body composition protocols Administration Route: Subcutaneous injection (abdomen, thigh, or upper arm) Reconstitution: Bacteriostatic water, standard peptide protocols Note: Clinical trials used oral formulations, but subcutaneous administration is more common in current use due to improved bioavailability